 Use leukocyte-depleted platelet concentrates prevention refractoriness primary HLA alloimmunization prospective randomized trial conventional transfusion strong reduction HLA alloimmunization refractoriness transfusions red blood cell concentrates RBCs platelet concentrates PCs leukocytes filtration leukocyte contamination transfusion RBCs filtration RBCs rational uncertainty degree leukocyte-depletion PCs prevention HLA alloimmunization refractoriness prospective trial randomized patients acute leukemia leukocyte-depleted PCs centrifugation mean leukocyte count /PC filtration mean leukocyte count /PC groups RBCs prior removal buffy coat Clinical refractoriness evaluable patients centrifuged PCs filtered group De anti-HLA antibodies patients group patients filtered PCs alloimmunized patients centrifuged group antibodies first weeks transfusion therapy none patients filtered group HLA period prevention HLA alloimmunization refractoriness transfusions random donors RBCs PCs leukocyte-depleted filtration